DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy
Authors
Keywords
Cancer, DNA damage, DNA repair, Chemotherapy, Carcinogenesis
Journal
Cancer Genetics
Volume 252-253, Issue -, Pages 6-24
Publisher
Elsevier BV
Online
2020-12-09
DOI
10.1016/j.cancergen.2020.12.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Potential of ATM Inhibitors
- (2020) Martin F Lavin et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Alkyladenine DNA glycosylase deficiency uncouples alkylation-induced strand break generation from PARP-1 activation and glycolysis inhibition
- (2020) Fahad A. Alhumaydhi et al. Scientific Reports
- CHK1/2 Inhibitor Prexasertib Suppresses NOTCH Signaling and Enhances Cytotoxicity of Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma
- (2020) Ling Zeng et al. MOLECULAR CANCER THERAPEUTICS
- Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer
- (2020) Whi-An Kwon et al. Translational Cancer Research
- Expression of DNA repair genes in oral squamous cell carcinoma using reverse transcription-quantitative polymerase chain reaction
- (2020) Mônica Ghislaine Oliveira Alves et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Exploiting DNA repair defects in colorectal cancer
- (2019) Nicole M. Reilly et al. Molecular Oncology
- Discovery of Isaindigotone Derivatives as Novel Bloom’s Syndrome Protein (BLM) Helicase Inhibitors That Disrupt the BLM/DNA Interactions and Regulate the Homologous Recombination Repair
- (2019) Qi-Kun Yin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Alterations in DNA damage repair genes in primary liver cancer
- (2019) Jianzhen Lin et al. CLINICAL CANCER RESEARCH
- Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
- (2019) Mingjing Shen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand
- (2019) Lin Mei et al. Journal of Hematology & Oncology
- Comparison of Autorefraction and Photorefraction with and without Cycloplegia Using 1% Tropicamide in Preschool Children
- (2019) Ertuğrul Tan Yassa et al. Journal of Ophthalmology
- DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas
- (2019) Bernd Kaina et al. DNA REPAIR
- DNA double-strand break repair-pathway choice in somatic mammalian cells
- (2019) Ralph Scully et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Role of the DNA damage response in prostate cancer formation, progression and treatment
- (2019) Wenhao Zhang et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era
- (2019) Vito Vanella et al. Current Oncology Reports
- Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer
- (2019) Mei Hua Jin et al. Cancer Research and Treatment
- Thyroid Cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes
- (2019) Santos et al. Genes
- DNA-PK as an Emerging Therapeutic Target in Cancer
- (2019) Ismail S. Mohiuddin et al. Frontiers in Oncology
- Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells
- (2019) Nicholas R. Jette et al. BRITISH JOURNAL OF CANCER
- Involvement of repair genes in oral cancer: A systematic review
- (2019) Alexandre Luiz Affonso Fonseca et al. CELL BIOCHEMISTRY AND FUNCTION
- The role of TP53 in acute myeloid leukemia: Challenges and opportunities
- (2019) Karina Barbosa et al. GENES CHROMOSOMES & CANCER
- Antibody–drug conjugates for cancer
- (2019) Cindy H Chau et al. LANCET
- ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers
- (2019) Tarek M. A. Abdel-Fatah et al. Cancers
- Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors
- (2019) Hui Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer
- (2019) Kyle C. Cuneo et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of Anthracycline-Enhanced Reactive Oxygen Metabolism in Tumor Cells
- (2019) James H. Doroshow Oxidative Medicine and Cellular Longevity
- Significance of TP53 mutation in bladder cancer disease progression and drug selection
- (2019) Guang Wu et al. PeerJ
- Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers
- (2018) N J Birkbak et al. ANNALS OF ONCOLOGY
- Topoisomerases as anticancer targets
- (2018) Justine L. Delgado et al. BIOCHEMICAL JOURNAL
- Roles of UVA radiation and DNA damage responses in melanoma pathogenesis
- (2018) Aiman Q. Khan et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNA
- (2018) Vincent Murray et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
- (2018) Mehdi Touat et al. JOURNAL OF CLINICAL INVESTIGATION
- Rice RAD51 paralogs play essential roles in somatic homologous recombination for DNA repair
- (2018) Zhan Xu et al. PLANT JOURNAL
- Systemic Therapy for Colon Cancer
- (2018) Christina Wu Surgical Oncology Clinics of North America
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- DNArCdb: A database of cancer biomarkers in DNA repair genes that includes variants related to multiple cancer phenotypes
- (2018) Pavel Silvestrov et al. DNA REPAIR
- Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia–mutated kinase–mediated DNA damage response
- (2018) Chao-Yuan Huang et al. EUROPEAN JOURNAL OF CANCER
- PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non-small-cell lung cancer
- (2018) Yu Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- Developing institutions for cancer care in low-income and middle-income countries: from cancer units to comprehensive cancer centres
- (2018) Bhawna Sirohi et al. LANCET ONCOLOGY
- Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?
- (2018) Ami N. Shah et al. ONCOLOGIST
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- Non-Hodgkin lymphoma
- (2018) Anna Bowzyk Al-Naeeb et al. BMJ-British Medical Journal
- The p53 Pathway in Glioblastoma
- (2018) Ying Zhang et al. Cancers
- Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
- (2018) Funda Meric-Bernstam et al. CLINICAL CANCER RESEARCH
- DNA repair pathways and cisplatin resistance: an intimate relationship
- (2018) CR Rocha et al. Clinics
- Diagnosis and Treatment of Ovarian Cancer
- (2018) Brian Orr et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants
- (2018) Stephanie Schubert et al. INTERNATIONAL JOURNAL OF CANCER
- Microscopic picture of water-ethylene glycol interaction near a model DNA by computer simulation: Concentration dependence, structure, and localized thermodynamics
- (2018) Atul Kumar Jaiswal et al. PLoS One
- Easy formulation of liposomal doxorubicin modified with a bombesin peptide analogue for selective targeting of GRP receptors overexpressed by cancer cells
- (2018) Antonella Accardo et al. Drug Delivery and Translational Research
- High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects
- (2018) Xia Li et al. EBioMedicine
- DNA Repair in Prostate Cancer: Biology and Clinical Implications
- (2017) Joaquin Mateo et al. EUROPEAN UROLOGY
- Bleomycin-induced chromosomal damage and shortening of telomeres in peripheral blood lymphocytes of incident cancer patients
- (2017) Michal Kroupa et al. GENES CHROMOSOMES & CANCER
- New Insights in Thyroid Cancer and p53 Family Proteins
- (2017) Livia Manzella et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma
- (2017) Erin M. Parry et al. Journal of Thoracic Oncology
- HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia
- (2017) S Tharkar-Promod et al. LEUKEMIA
- ASF1a Promotes Non-homologous End Joining Repair by Facilitating Phosphorylation of MDC1 by ATM at Double-Strand Breaks
- (2017) Kyung Yong Lee et al. MOLECULAR CELL
- Regulation of the DNA Damage Response by DNA-PKcs Inhibitory Phosphorylation of ATM
- (2017) Yi Zhou et al. MOLECULAR CELL
- Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy
- (2017) Kenneth M. Felsenstein et al. Nature Reviews Urology
- Genome-wide prediction of minor-groove electrostatic potential enables biophysical modeling of protein–DNA binding
- (2017) Tsu-Pei Chiu et al. NUCLEIC ACIDS RESEARCH
- ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib
- (2017) Chen Wang et al. Translational Oncology
- Downregulated XPA promotes carcinogenesis of bladder cancer via impairment of DNA repair
- (2017) Yi Zhi et al. TUMOR BIOLOGY
- Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis
- (2017) Zhun Wang et al. Oncotarget
- Suppression of homology-dependent DNA double-strand break repair induces PARP inhibitor sensitivity in VHL-deficient human renal cell carcinoma
- (2017) Susan E. Scanlon et al. Oncotarget
- Inhibiting translesion DNA synthesis as an approach to combat drug resistance to DNA damaging agents
- (2017) Jung-Suk Choi et al. Oncotarget
- KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
- (2017) Jonas Cicenas et al. Cancers
- Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
- (2016) Erlinda M. Gordon et al. ADVANCES IN THERAPY
- Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma
- (2016) T. Kunicka et al. BMC CANCER
- Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells
- (2016) Concepción Fernández-Rodríguez et al. LEUKEMIA & LYMPHOMA
- Role of nucleotide excision repair proteins in response to DNA damage induced by topoisomerase II inhibitors
- (2016) Jaqueline C. Rocha et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- DNA repair mechanisms and their clinical impact in glioblastoma
- (2016) Hélène Erasimus et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma
- (2016) Anne Catherine Bretz et al. NUCLEIC ACIDS RESEARCH
- Mechanisms of small molecule–DNA interactions probed by single-molecule force spectroscopy
- (2016) Ali A. Almaqwashi et al. NUCLEIC ACIDS RESEARCH
- Familial pancreatic cancer
- (2016) Gloria M. Petersen SEMINARS IN ONCOLOGY
- Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored
- (2016) Stephen K.H. Li et al. TRENDS IN MOLECULAR MEDICINE
- Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma
- (2016) Pei-Yu Huang et al. Oncotarget
- Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
- (2016) Andrea Ghelli Luserna Di Rorà et al. Oncotarget
- Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair
- (2016) Timothy Budden et al. Oncotarget
- TP53Mutations in Breast and Ovarian Cancer
- (2016) Laxmi Silwal-Pandit et al. Cold Spring Harbor Perspectives in Medicine
- Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
- (2016) Mohammad A. Jafri et al. Genome Medicine
- ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells
- (2015) M. Kwok et al. BLOOD
- Identification of germline genetic mutations in patients with pancreatic cancer
- (2015) Erin E. Salo-Mullen et al. CANCER
- Antimitotic drugs in the treatment of cancer
- (2015) Rustelle Janse van Vuuren et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Xeroderma pigmentosum group C sensor: unprecedented recognition strategy and tight spatiotemporal regulation
- (2015) Marjo-Riitta Puumalainen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells
- (2015) Ling Li et al. CURRENT OPINION IN HEMATOLOGY
- Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links
- (2015) Akshada Sawant et al. DNA REPAIR
- Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
- (2015) Elizabeth R. Plimack et al. EUROPEAN UROLOGY
- Chemotherapy is getting ‘smarter’
- (2015) Thomas Mehrling Future Oncology
- The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect
- (2015) Tingting Zhang et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma
- (2015) Spring Holter et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Variants in Fanconi Anemia Pathway Genes BRCA2 and FANCA Predict Melanoma Survival
- (2015) Jieyun Yin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mitoxantrone, More than Just Another Topoisomerase II Poison
- (2015) Benny J. Evison et al. MEDICINAL RESEARCH REVIEWS
- Anthracyclines induce double-strand DNA breaks at active gene promoters
- (2015) Fan Yang et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- ATM and ATR as therapeutic targets in cancer
- (2015) Anika Maria Weber et al. PHARMACOLOGY & THERAPEUTICS
- Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer
- (2015) Junli Ma et al. TUMOR BIOLOGY
- A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cells
- (2015) Jing Yu et al. Oncotarget
- 5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair
- (2015) Upadhyayula Sai Srinivas et al. Oncotarget
- Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer
- (2015) Richarda M. de Voer et al. Scientific Reports
- An overview of doxorubicin formulations in cancer therapy
- (2015) Sangeeta Rivankar Journal of Cancer Research and Therapeutics
- PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitrohepatocellular carcinoma models
- (2014) Clément Guillot et al. BMC CANCER
- Optimized thermosensitive liposomes for selective doxorubicin delivery: Formulation development, quality analysis and bioactivity proof
- (2014) I. Levacheva et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Recent advances in small organic molecules as DNA intercalating agents: Synthesis, activity, and modeling
- (2014) Antonio Rescifina et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Genetic Variation in DNA Repair Pathways and Risk of Non-Hodgkin's Lymphoma
- (2014) Justin Rendleman et al. PLoS One
- Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
- (2014) Felix Dietlein et al. TRENDS IN GENETICS
- ATM Regulates 3-Methylpurine-DNA Glycosylase and Promotes Therapeutic Resistance to Alkylating Agents
- (2014) S. Agnihotri et al. Cancer Discovery
- Molecular aspects of cancer cell resistance to chemotherapy
- (2013) Magali Rebucci et al. BIOCHEMICAL PHARMACOLOGY
- DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
- (2013) Kahlin Cheung-Ong et al. CHEMISTRY & BIOLOGY
- The complex genetic landscape of familial breast cancer
- (2013) Lorenzo Melchor et al. HUMAN GENETICS
- Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer
- (2013) M. A. Batey et al. MOLECULAR CANCER THERAPEUTICS
- Contribution of ATM and ATR to the Resistance of Glioblastoma and Malignant Melanoma Cells to the Methylating Anticancer Drug Temozolomide
- (2013) Marcus Eich et al. MOLECULAR CANCER THERAPEUTICS
- Fanconi anaemia and the repair of Watson and Crick DNA crosslinks
- (2013) Molly C. Kottemann et al. NATURE
- On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
- (2013) Chyuan-Chuan Wu et al. NUCLEIC ACIDS RESEARCH
- Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
- (2013) Smita Bhatia SEMINARS IN ONCOLOGY
- Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways
- (2012) R.A. Bilardi et al. BIOCHEMICAL PHARMACOLOGY
- Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer
- (2012) Sandra Salvi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Polymorphisms of Base-Excision Repair Genes hOGG1 326cys and XRCC1 280His Increase Hepatocellular Carcinoma Risk
- (2012) Tao Yuan et al. DIGESTIVE DISEASES AND SCIENCES
- Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway
- (2012) H. Kim et al. GENES & DEVELOPMENT
- Chemistry of DNA minor groove binding agents
- (2012) Gul Shahzada Khan et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence
- (2012) Weiya Z. Wysham et al. PLoS One
- DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells
- (2011) Moriya Iwaizumi et al. CANCER BIOLOGY & THERAPY
- FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons
- (2011) Lisa A. Kachnic et al. CANCER LETTERS
- Both XPA and DNA polymerase eta are necessary for the repair of doxorubicin-induced DNA lesions
- (2011) Maria Carolina S. Moraes et al. CANCER LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Treatment of Advanced Medullary Thyroid Carcinoma with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine: a Single-Center Experience
- (2011) T. Deutschbein et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- TP53 Mutations in Nonsmall Cell Lung Cancer
- (2011) Akira Mogi et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- All tangled up: how cells direct, manage and exploit topoisomerase function
- (2011) Seychelle M. Vos et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Ipilimumab plus Dacarbazine in Melanoma
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Temozolomide: Mechanisms of Action, Repair and Resistance
- (2011) Jihong Zhang et al. Current Molecular Pharmacology
- Evaluation of ERCC1 Expression for Cisplatin Sensitivity in Human Hepatocellular Carcinoma
- (2010) Shigeru Ueda et al. ANNALS OF SURGICAL ONCOLOGY
- Interrogation of Nucleotide Excision Repair Capacity: Impact on Platinum-Based Cancer Therapy
- (2010) Jennifer N. Earley et al. ANTIOXIDANTS & REDOX SIGNALING
- Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt
- (2010) THANAA E.A. HELAL et al. APMIS
- Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies
- (2010) Min Shen et al. BRITISH JOURNAL OF HAEMATOLOGY
- DNA damage induced by the anthracycline cosmomycin D in DNA repair-deficient cells
- (2010) Helotonio Carvalho et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Deficiency of FANCD2-Associated Nuclease KIAA1018/FAN1 Sensitizes Cells to Interstrand Crosslinking Agents
- (2010) Katja Kratz et al. CELL
- Importance of the cell cycle phase for the choice of the appropriate DSB repair pathway, for genome stability mintenance: the trans-S double-strand break repair model
- (2010) Fabien Delacôte et al. CELL CYCLE
- Alkyltransferase-like proteins: molecular switches between DNA repair pathways
- (2010) Julie L. Tubbs et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- DNA Repair Pathways and Human Metastatic Malignant Melanoma
- (2010) A. Sarasin et al. CURRENT MOLECULAR MEDICINE
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- A Review of Trabectedin (ET-743): A Unique Mechanism of Action
- (2010) Maurizio D'Incalci et al. MOLECULAR CANCER THERAPEUTICS
- Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor
- (2010) Sushant K. Kachhap et al. PLoS One
- DNA minor groove binders: Back in the groove
- (2009) Xuemei Cai et al. CANCER TREATMENT REVIEWS
- DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome
- (2009) George Poulogiannis et al. HISTOPATHOLOGY
- XPF-ERCC1 Participates in the Fanconi Anemia Pathway of Cross-Link Repair
- (2009) N. Bhagwat et al. MOLECULAR AND CELLULAR BIOLOGY
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
- Up-regulation of WRN and DNA ligase III in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks
- (2008) A. Sallmyr et al. BLOOD
- Genetic Susceptibility to Renal Cell Carcinoma: The Role of DNA Double-Strand Break Repair Pathway
- (2008) V. Margulis et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Participation of DNA repair in the response to 5-fluorouracil
- (2008) M. D. Wyatt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- DNA topoisomerases: harnessing and constraining energy to govern chromosome topology
- (2008) Allyn J. Schoeffler et al. QUARTERLY REVIEWS OF BIOPHYSICS
- DNA repair in response to anthracycline–DNA adducts: A role for both homologous recombination and nucleotide excision repair
- (2007) Damian M.S. Spencer et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now